Please login to the form below

Not currently logged in
Email:
Password:

Rising cost of Spanish prescription costs

Patients in Spain over the age of 65-years-old are paying six times more than younger people for prescriptions

Patients in Spain over the age of 65-years-old are paying six times more than younger people for prescriptions.

According to a study of 5.47 million patients in the Spanish region of Catalonia showed that there are significant differences in prescription costs based on people's age.

Details of the study conducted by researchers from the University of Barcelona were published the March issue of the British Journal of Clinical Pharmacology.

Professor Eduardo Marino from the faculty of pharmacy at the University of Barcelona said: "Our population is progressively ageing, we are better at detecting problems than 15 years ago and more expensive drugs are being developed."

People over the age of 75-years-old had almost eight times as many prescriptions as children under 4-years-old.

By breaking down patients into ten different age categories and looking at their use of 15 different drugs, the research team was able to, "build up a very clear picture of what sort of drugs people were taking, depending on their age and gender."

13th March 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics